Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 261,458 | 265,002 | 259,769 | 239,897 | 228,528 |
| Cost of Goods | 119,195 | 128,691 | 121,204 | 117,356 | 120,443 |
| Gross Profit | 142,263 | 136,311 | 138,565 | 122,541 | 108,085 |
| Operating Expenses | 111,691 | 117,803 | 103,118 | 98,387 | 107,138 |
| Operating Income | 30,767 | 19,199 | 35,651 | 24,510 | 1,390 |
| Interest Expense | 5,273 | 3,872 | 4,263 | 4,588 | 4,398 |
| Pre-tax Income | 25,494 | 15,327 | 31,388 | 19,922 | -3,008 |
| Income Tax | 5,617 | 5,586 | 8,156 | 5,066 | 1,446 |
| Net Income Continuous | 19,877 | 9,741 | 23,232 | 14,856 | -4,454 |
| Net Income | $19,877 | $9,741 | $23,232 | $14,856 | $-4,454 |
| EPS Basic Total Ops | 0.39 | 0.20 | 0.45 | 0.29 | -0.09 |
| EPS Basic Continuous Ops | 0.39 | 0.19 | 0.45 | 0.29 | -0.09 |
| EPS Diluted Total Ops | 0.38 | 0.19 | 0.45 | 0.29 | -0.09 |
| EPS Diluted Continuous Ops | 0.38 | 0.19 | 0.45 | 0.29 | -0.09 |
| EBITDA(a) | $54,011 | $44,808 | $60,813 | $48,838 | $27,442 |